KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹26 Cr | ₹39 Cr | ₹51 Cr | ₹27 Cr | ₹61 Cr |
What is the latest Consolidated Net Profit of KOPRAN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹26 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹61 Cr |
How is Consolidated Net Profit of KOPRAN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | -33.26 | |
| Mar2025 | ₹39 Cr | -24.34 | |
| Mar2024 | ₹51 Cr | 87.11 | |
| Mar2023 | ₹27 Cr | -55.38 | |
| Mar2022 | ₹61 Cr | - | |
Compare Consolidated Net Profit of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹925.9 Cr | -2.5% | 0.7% | 20.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.5% |
0.7% |
20.6% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses